These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Clinico-pharmacologic aspects of therapy with enoximone]. Trenk D; Jähnchen E Z Kardiol; 1994; 83 Suppl 2():7-14. PubMed ID: 8091828 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenous enoximone in dialysis patients. Fiegel P; Trenk D; Jaehnchen E; Dieterich HA J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S20-3. PubMed ID: 2480480 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation]. Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839 [TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience. Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876 [TBL] [Abstract][Full Text] [Related]
17. Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration. Mitrovic V; Petrovic O; Bahavar H; Neuzner J; Dieterich HA; Schlepper M Cardiovasc Drugs Ther; 1991 Aug; 5(4):689-95. PubMed ID: 1832289 [TBL] [Abstract][Full Text] [Related]
18. Differential hemodynamic effects of oral enoximone in severe congestive heart failure. Murali S; Uretsky BF; Betschart AR; Tokarczyk TR; Kolesar JA; Reddy PS Am J Cardiol; 1990 Feb; 65(7):515-9. PubMed ID: 2137668 [No Abstract] [Full Text] [Related]
19. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results]. Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628 [TBL] [Abstract][Full Text] [Related]
20. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. Weber KT; Janicki JS; Jain MC J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]